Eikon Therapeutics, Inc. (EIKN) has 6 open-market insider trades by 7 insiders since 2026. Over the last six months insiders net bought $1.0M. The most active filer is Column Group IV GP, LP, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Column Group IV GP, LP via David V. Goeddel | 10% Owner | — | 2 | $39.2M | 2026-09-03 |
| Column Group Opportunity III, LP | 10% | — | 1 | $38.1M | 2026-02-06 |
| Josh Wolfe | Dir10% | — | 1 | $2.5M | 2026-02-06 |
| Ventures V. L.p. Lux | 10% | — | 1 | $2.5M | 2026-02-06 |
| Kenneth C. Frazier | Dir | — | 1 | $2.0M | 2026-02-04 |
| Foresite Capital Management IV, LLC | 10% Owner | — | 1 | $1000K | 2026-02-04 |
| Foresite Capital Opportunity Management V, LLC | 10% | — | 1 | $1000K | 2026-02-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Column Group IV GP, LP | 10% Owner | Buy | $1.0M | 2026-09-03 |
| Column Group IV GP, LP | 10% Owner | Buy | $38.1M | 2026-02-06 |
| Josh Wolfe | Director & 10% | Buy | $2.5M | 2026-02-04 |
| Foresite Capital Opportunity Management V, LLC | 10% | Buy | $1000K | 2026-02-04 |
| Kenneth C. Frazier | Director | Buy | $2.0M | 2026-02-04 |
Companies that share insiders with EIKN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.